# Definitive Contract #80NSSC26C0239

Definitive Contract for Microgravity Cancer Research Organoid Screening

**Buyer:** National Aeronautics and Space Administration

**Award Amount:** $224,161.00
**Ceiling:** $224,161.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Oct 29, 2027

**Identifier:** 80NSSC26C0239
**NAICS:** 541713

This award represents a definitive contract granted to ExoSpheres, Inc., a company specializing in advanced biological research, to conduct an innovative project focused on complex organoid screening in microgravity environments targeting intractable cancers. The contract emphasizes pioneering biomedical research with the potential to advance cancer treatment methods using microgravity's unique environment to better understand tumor behavior. The scope includes developing and screening organoid models under microgravity conditions to identify novel insights that could lead to breakthroughs in cancer therapies. Awarded through a competitive process, the contract signifies a critical investment by the agency in pioneering space-based biomedical research. The work is scheduled to be performed in Dover, Delaware, over a one-year period, highlighting a substantial commitment to this cutting-edge scientific endeavor. No contract vehicle, subcontractors, acquisition programs, or prior related contracts were specified for this award.

### Description

STTR PHASE I COMPLEX ORGANOID SCREENING IN MICROGRAVITY FOR INTRACTABLE CANCERS

[View original record](https://www.usaspending.gov/award/CONT_AWD_80NSSC26C0239_8000_-NONE-_-NONE-)